Conference Description

May 20, 2006
Doubletree Guest Suites Naples
12200 Tamiami Trail North
Naples, Florida
(239) 593-8733

Tell a friend about this conference

Download the brochure for this conference

CME Credits: 7.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants.

Program Summary:
This program will provide Primary Care Physicians the opportunity to learn first hand from national thought leaders in their field. The goal is to provide a clearer understanding of several of the most common disease processes, in light of rapid scientific advances. By doing so, attendees will walk away with new insights and learn useful strategies to manage the challenges faced on a daily basis.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. identify surrogates of mortality in COPD and better utilize targeted patient interventions that improve patient’s outcomes
2. discuss recent advances in Pulmonary Hypertension, screening and workup and review novel treatments for this disease
3. more fully understand the prevalence of the metabolic syndrome, explain its clinical significance and outline an approach to its management
4. review the pathophysiology of type 2 diabetes; understand which interventions can be used to treat hyperglycemia and other metabolic abnormalities, thereby preventing many complications with early, aggressive therapy
5. understand the role for insulin in patients with type 2 diabetes and develop strategies for initiating and adjusting therapy
6. more clearly comprehend the impact of the Renin Angiotensin System in Hypertension and its role in cardiovascular disease
7. evaluate and diagnose the anemia of chronic kidney disease, understand its impact on quality of life, and guide treatment decisions based on emerging data

Agenda:

7:30-8:10 am		Registration, Continental Breakfast and Welcome
8:10-8:20		Welcome Remarks Gregg Sherman, MD
8:20-9:20		Evaluating disease severity in COPD: The value of patient centered outcomes Claudia Cote, MD
9:20-10:20		Diagnosis and Management of Pulmonary Hypertension Franck F. Rahaghi, MD, MHS, FCCP
10:20-10:40		Break
10:40-11:40		Identification and Applications of the Metabolic Syndrome to Clinical Practice Ron Goldberg, MD
11:40-12:40		Management of Type 2 Diabetes: The Need for Early, Aggressive Intervention Ron Goldberg, MD
12:40-1:30		Lunch
1:30-2:30		Optimizing Therapy with Insulin in Type 2 Diabetes Luigi Meneghini, MD
2:30-3:30		Hypertension - The Role of the Renin-Angiotensin System, Focus on Target Organ Damage Josh Furman, MD
3:30-3:50		Break
3:50-4:50		Anemia in Chronic Kidney Disease: Clinical Implications and Treatment Options Jeffrey Berns, MD
4:50-5:00		Conference Wrap Up Gregg Sherman, MD

Faculty:
Jeffrey Berns, MD
University of Pennsylvania School of Medicine
Renal, Electrolyte, and Hypertension Division
Penn Presbyterian Medical Center
Philadelphia, PA

Claudia G. Cote, M.D. FCCP.
Pulmonary and Critical Care Division
Bay Pines VA Medical Center

Joshua Furman, MD, FACC
Mount Sinai Medical Center
Miami Beach, Florida

Ronald Goldberg, MD
Professor of Medicine in the Division of Endocrinology, Diabetes
and Metabolism Associate Director of the Diabetes Research Institute and Director of the Lipid Disorders Unit in Miami

Luigi Meneghini, M.D., M.B.A.
Associate Professor of Clinical Medicine
Director, Kosow Diabetes Treatment Center
Diabetes Research Institute
University of Miami School of Medicine

Franck F. Rahaghi, MD, MHS, FCCP
Director, Pulmonary Hypertension Clinic
Pulmonary and Critical Care
Cleveland Clinic Florida at Weston

Program Chair: Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.0 Prescribed credits by the American Academy of Family Physicians.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 7 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 8.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Actellion, Amgen, Boehringer Ingelheim, Bristol-Myers Squibb, Novo nordisk, Pfizer, sanofi-aventis, Takeda, Wyeth.